Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) Announces Dividend of $0.09

Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) announced a dividend on Monday, March 3rd, NASDAQ Dividends reports. Shareholders of record on Friday, March 14th will be paid a dividend of 0.0862 per share on Monday, March 31st. The ex-dividend date of this dividend is Friday, March 14th.

Brooklyn ImmunoTherapeutics Price Performance

NYSE BTX traded down $0.07 during midday trading on Tuesday, hitting $6.90. 880,933 shares of the company traded hands, compared to its average volume of 816,089. The company has a market cap of $405.90 million, a PE ratio of -3.04 and a beta of 4.61. The company’s 50-day simple moving average is $1.61 and its 200-day simple moving average is $1.24. Brooklyn ImmunoTherapeutics has a 52 week low of $6.66 and a 52 week high of $8.31.

Analysts Set New Price Targets

Separately, StockNews.com began coverage on Brooklyn ImmunoTherapeutics in a research report on Wednesday, February 26th. They set a “hold” rating on the stock.

Brooklyn ImmunoTherapeutics Company Profile

Eterna Therapeutics, Inc is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.